Zikani Therapeutics
Latest round
- Series A
Last raised
- Apr 2020
Total raised
- $20M
Investors
- 5
About Zikani Therapeutics
, is a preclinical-stage company that focuses on developing novel antibiotic compounds to relieve patient suffering from serious infections and rare diseases.
Who invested in Zikani Therapeutics
5 investors across 3 rounds
See all investors in Zikani Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zikani Therapeutics
Who invested in Zikani Therapeutics?
Zikani Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zikani Therapeutics raised?
Zikani Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zikani Therapeutics last raise money?
Zikani Therapeutics's most recent round on record is a Series A, in Apr 2020.
What does Zikani Therapeutics do?
, is a preclinical-stage company that focuses on developing novel antibiotic compounds to relieve patient suffering from serious infections and rare diseases.
Where is Zikani Therapeutics headquartered?
Zikani Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Zikani Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Zikani Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Zikani Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.